Tampilkan postingan dengan label Trauma. Tampilkan semua postingan
Tampilkan postingan dengan label Trauma. Tampilkan semua postingan

Rabu, 05 April 2017

Trauma Insurance For Neuropathy


Today's interesting post from lifeinsurancefinder.com.au (see link below) talks about the possibility of being covered by a trauma insurance in the event of contracting neuropathy. I've certainly never heard of such an insurance in the Netherlands and because it's an Australian article, it's possible that it only applies in certain countries. Whatever the range, this sort of insurance policy seems to be a very good thing for neuropathy sufferers although I assume that you couldn't take the insurance out retrospectively. It will be an insurance meant to cover future events and not if you're already suffering.
Many people may be able to take out insurances to cover loss of work through unpredicted illness but this may be something different. Certainly an interesting idea.

Peripheral neuropathy

Last Updated January 21st, 2011 by Life Insurance Finder
The Australian Bureau of Statistics (ABS) released data in 2008 that indicated two in three men and one in three women are likely to suffer a traumatic event during their working lifetime. One of the many traumatic events they included in their survey was peripheral neuropathy. The odds of two in three men or one in three women is not good and for this reason life insurance companies offer financial protection in the way of trauma insurance.

Peripheral neuropathy is the occasioning of damage to the peripheral nervous system, the manner in which information is transmitted from the brain and spinal cord to every other part of the body. In fact there are more than 100 types of peripheral neuropathy that have been discovered within the human body, each one with its own characteristic set of symptoms, development and prognosis.

Life insurance companies, through their trauma insurance, are helping sufferers to cope with this debilitating disease that is becoming more endemic in the community because of it close link to diabetes which has grown prolifically in recent years in western countries. This assistance is by the way of a lump sum payment on a positive diagnosis of the condition. This money can then be used to pay off existing debts, mortgage repayments etc. so the sufferer has at least one less problem to worry about.

Some sufferers may experience temporary numbness, pricking or tingling sensations, sensitivity to touch, or muscle weakness. Others may suffer more extreme symptoms, organ or gland dysfunction, paralysis, muscle wasting, or burning pains at night, as the impaired function and symptoms depend on the type of nerves affected – autonomic, sensory or motor.
There are two ways in which peripheral neuropathy can be contracted, either by inheritance or acquisition:
  • Sufferers who have inherited the disease have done so through either inborn mistakes in the genetic code or by new genetic mutations, for which there is no cure.
  • Acquired peripheral neuropathy can result because of a physical injury to a nerve, tumours, toxins, autoimmune responses, nutritional deficiencies, alcoholism and vascular and metabolic disorders. This often comes about because of systemic disease, autoimmune disorders affecting nerve tissue, infections, or from trauma brought about by some external agent.
Acquired peripheral neuropathy can be treated in many ways such as:
  • Adopting healthy habits.
  • Avoid exposure to toxins.
  • Following a doctor supervised exercise program.
  • Eating a balanced diet.
  • Correcting vitamin deficiencies.
  • Limit alcohol consumption.
All these actions can help reduce the emotional and physical effects of peripheral neuropathy as trauma insurance offered by life insurance companies can reduce the financial effects. Systemic diseases often require much more complex treatments.

In acute neuropathies, such as Guillain-Barr syndrome, the symptoms suddenly appear and develop fast, they also tend to resolve slowly as the damaged nerves heal following successful treatment. In its chronic form the symptoms appear subtly and develop slowly. Many sufferers occasion periods of relief only to be followed by a relapse. Others may get to a certain level where the symptoms remain static without change for many months, even years. Some worsen over time but very few prove to be fatal unless complicated by other illnesses. Occasionally peripheral neuropathy is a symptom of another disorder.
Since each life insurance company defines trauma insurance conditions differently it is very important to closely read the policy conditions and definitions before making any final decision to take out the cover. This early caution may save you a lot of emotional stress in the event of you making a claim in later years.

Most life insurance companies offer trauma insurance to people between 17 and 59 years of age and allow it to be renewed until the policy anniversary date prior to the insured’s 80th birthday, although it is important to keep in mind that after the insured person reaches the age of 70 years, the cover often reduces automatically to that of ‘Loss of independent Existence’. Trauma cover benefits are paid in a lump sum if the insured survives for 14 days following the occurrence of many specified major medical conditions outlined in the policy document and the cover is available as part of the life insurance policy or as a standalone cover.

The amount of trauma insurance you need to take out is purely a personal individual decision you yourself will have to determine. In making this decision you should consider your cost of living expenses and any medical costs that may be associated with your illness including any rehabilitation expenses. In short your insurance cover should be sufficient to pay off all your debts so you can concentrate on getting well again without having to worry about your finances.

http://www.lifeinsurancefinder.com.au/diseases-and-health-conditions/peripheral-neuropathy/

Kamis, 06 Oktober 2016

Nerve Grafting Possible To Help Trauma Induced Neuropathy


Today's post from sciencedaily.com (see link below) looks at the possibility of using complex nerve grafting (TENGs - tissue-engineered nerve grafts) to restore nerve function after traumatic physical injuries. Neuropathy is frequently the result of accidents (one of the 100+ causes) but the problem lies in restoring nerve function over long distances in the body.Nerve cells communicate with each other via axons, which are long projections connecting neurons to each other - the problem is encouraging axons to regenerate if they're broken. TENGs are if you like, lab-grown axons and are meant to form a connecting web for nerve cells. Of course it's not as easy as it sounds, as this article highlights.

Value of tissue-engineering to repair major peripheral nerve injuries demonstrated Source:Perelman School of Medicine at the University of Pennsylvania Date:January 31, 2015

Summary:

Peripheral nerve injury (PNI) is a common consequence of traumatic injuries, wounds caused by an external force or an act of violence, such as a car accident, gun shot or even surgery. In those injuries that require surgical reconstruction, outcomes can result in partial or complete loss of nerve function and a reduced quality of life. But, researchers at Penn Medicine have demonstrated a novel way to regenerate long-distance nerve connections in animal models using tissue-engineered nerve grafts (TENGs). Their work was presented earlier this month at the annual meeting of the American Society for Peripheral Nerve (ASPN) at the Atlantis Resort, Paradise Island, Bahamas.

Nerve cells or neurons work by growing axons, long fibrous projections that connect neurons and form the body's signal transmission and communication structure. Although new neurons are born, the long axon cables that connect them do not regenerate effectively over long distances, yet they are necessary for normal function. Researchers have been working for decades to coax damaged axons to regenerate, with little success in getting enough axons to grow to the right places.

"Despite considerable progress in research and surgical techniques, treatment of peripheral nerve injury remains challenging," said D. Kacy Cullen, PhD, assistant professor of Neurosurgery at the Perelman School of Medicine at the University of Pennsylvania. "Our results demonstrate for the first time some promise for patients who experience a loss of peripheral nerve function as a result of surgery or traumatic injury, including those experienced by members of the military."

TENGs are lab-grown nervous tissue comprised of long axonal tracts spanning neurons. The ability to generate TENGs is based upon a mechanism of axon "stretch growth" established by Douglas H. Smith, MD, Robert A. Groff Professor of Teaching and Research in Neurosurgery and director of the Center for Brain Injury and Repair at Penn. These tissues are not only similar in structure to endogenous nerves, but suitable for transplantation upon removal from custom bioreactors.

There are currently no commercially available nerve grafts capable of consistently facilitating axon regeneration across major nerve lesions, generally considered to be a loss of a nerve segment five centimeters or longer. In one of two new studies, the Penn team demonstrated the success of TENGs in driving axon regeneration across five centimeter nerve lesions in the legs of pigs (in 10 out of 10 subjects). The living TENGs were surgically attached to bridge a missing segment of nerve and were shown to accelerate the regeneration of axons, allowing a population of axons to cross the graft within five weeks. At three months, the bulk of axons had crossed the graft into the existing nerve structures opposite the lesion. Target muscle reinnervation was confirmed via an evoked hoof twitch as early as seven months following TENG repair, and over nine to eleven months post-repair there were steady increases in muscle electrical activity and muscle force generation. Microscopic examination of the regenerated nerves revealed a high density of regrown axons bridging the lesion zone and progressing the length of the repaired nerve to innervate target muscle.

In a separate study, Cullen, Smith and colleagues were able to show the value of living neurons in TENGs to maintain the pro-regenerative capacity of degenerated nerve segments, relevant for even longer peripheral nerve injuries. As time passes after injury, the nerve's capacity for potential regeneration diminishes, so Cullen and team looked to TENGs to "babysit" the support cells -- referred to as Schwann cells (SCs) -- that are necessary to facilitate ultra-long distance axon regeneration. The team was able to implant living TENG neurons in a rat model of chronic axotomy -- mimicking the state of nerve segments far distal from a primary nerve injury which do not see axons for the many months necessary for axons to regenerate -- to prolong the pro-generative capacity of nerves.

SCs initially assumed a pro-regenerative alignment, which was maintained over two to four weeks. However, in the control group (which did not receive TENGs), this pro-regenerative structure was gradually lost, with significant degeneration seen at six to eight weeks and a complete absence of SC alignment by 16 weeks. Conversely, in animals receiving TENGs, surviving graft neurons were observed, as well as graft axon penetration into the nerves and interaction with host SCs. With TENG treatment, pro-regenerative host SCs were maintained to at least 16 weeks post-axotomy, demonstrating the promise of living axonal constructs to maintain the regenerative capacity in the distal nerve segment.

The team is currently assessing the ability of their unique tissue-engineering based bridging strategy together with their babysitting strategy in an even more challenging peripheral nerve injury model in pigs. Ultimately, the Penn research team is confident that this joint approach may provide functional recovery following currently untreatable peripheral nerve injuries, allowing full limb function and sensation to improve the quality of life for afflicted patients.

Story Source:


The above story is based on materials provided by Perelman School of Medicine at the University of Pennsylvania. Note: Materials may be edited for content and length. 


http://www.sciencedaily.com/releases/2015/01/150131071815.htm